These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
452 related items for PubMed ID: 17287051
1. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Grunow R, Porsch-Ozcürümez M, Splettstoesser W, Buckendahl A, Hahn U, Beyer W, Böhm R, Huber M, vd Esche U, Bessler W, Frangoulidis D, Finke EJ. Vaccine; 2007 May 04; 25(18):3679-83. PubMed ID: 17287051 [Abstract] [Full Text] [Related]
10. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits. Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE. FEMS Immunol Med Microbiol; 2009 Nov 15; 57(2):165-72. PubMed ID: 19732139 [Abstract] [Full Text] [Related]
13. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Price BM, Liner AL, Park S, Leppla SH, Mateczun A, Galloway DR. Infect Immun; 2001 Jul 15; 69(7):4509-15. PubMed ID: 11401993 [Abstract] [Full Text] [Related]
14. Molecular basis for improved anthrax vaccines. Brey RN. Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1266-92. PubMed ID: 15935874 [Abstract] [Full Text] [Related]
15. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components. Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A. Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760 [Abstract] [Full Text] [Related]